Cargando…

Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure

OBJECTIVE: The aim was to co-produce and test a potential new patient-reported outcome measure (PROM), the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd), providing vital qualitative confirmation of conceptual relevance, clarity and acceptability. METHODS: Informed by meas...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson, Nathan A, Tutton, Elizabeth, Martindale, Jane, Strickland, George, Thompson, Jean, Packham, Jonathan C, Creamer, Paul, Haywood, Kirstie L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021732/
https://www.ncbi.nlm.nih.gov/pubmed/35465627
http://dx.doi.org/10.1093/rap/rkac027
_version_ 1784689898549149696
author Pearson, Nathan A
Tutton, Elizabeth
Martindale, Jane
Strickland, George
Thompson, Jean
Packham, Jonathan C
Creamer, Paul
Haywood, Kirstie L
author_facet Pearson, Nathan A
Tutton, Elizabeth
Martindale, Jane
Strickland, George
Thompson, Jean
Packham, Jonathan C
Creamer, Paul
Haywood, Kirstie L
author_sort Pearson, Nathan A
collection PubMed
description OBJECTIVE: The aim was to co-produce and test a potential new patient-reported outcome measure (PROM), the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd), providing vital qualitative confirmation of conceptual relevance, clarity and acceptability. METHODS: Informed by measurement theory, we collaborated with patient partners throughout a three-stage, iterative process of PROM development. In stage 1, informed by patient interviews, reviews exploring patients’ fatigue experiences and existing PROMs of fatigue, an initial measurement framework of axial spondyloarthritis (axSpA) fatigue and energy and candidate items were defined. In stage 2, the relevance and acceptability of the measurement framework and candidate items were assessed qualitatively by focus group participants. In stage 3, patients participated in pre-testing interviews to assess item comprehensiveness, relevance, acceptability and comprehensibility. RESULTS: Stage 1 informed the development of an initial five-domain measurement framework with 59 candidate items. In stage 2, five patients and seven health-care professionals participated in four focus groups to derive a 40-item model of fatigue and energy. Collaborative engagement with patient research partners supported refinement of questionnaire structure and content further. Pre-testing with ten patients across two interview rounds in stage 3 produced a four-domain, 30-item long-form questionnaire. CONCLUSION: An active collaboration with patients and health-care professionals has supported the co-production of a potential new PROM of axSpA fatigue, underpinned by strong evidence of face and content validity. The WASTEd extends the assessment of fatigue beyond severity, highlighting the importance of symptom frequency, energy and self-management. Future research will involve psychometric evaluation, supporting item reduction, structural refinement and confirmation of PROM validity.
format Online
Article
Text
id pubmed-9021732
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-90217322022-04-21 Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure Pearson, Nathan A Tutton, Elizabeth Martindale, Jane Strickland, George Thompson, Jean Packham, Jonathan C Creamer, Paul Haywood, Kirstie L Rheumatol Adv Pract Original Article OBJECTIVE: The aim was to co-produce and test a potential new patient-reported outcome measure (PROM), the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd), providing vital qualitative confirmation of conceptual relevance, clarity and acceptability. METHODS: Informed by measurement theory, we collaborated with patient partners throughout a three-stage, iterative process of PROM development. In stage 1, informed by patient interviews, reviews exploring patients’ fatigue experiences and existing PROMs of fatigue, an initial measurement framework of axial spondyloarthritis (axSpA) fatigue and energy and candidate items were defined. In stage 2, the relevance and acceptability of the measurement framework and candidate items were assessed qualitatively by focus group participants. In stage 3, patients participated in pre-testing interviews to assess item comprehensiveness, relevance, acceptability and comprehensibility. RESULTS: Stage 1 informed the development of an initial five-domain measurement framework with 59 candidate items. In stage 2, five patients and seven health-care professionals participated in four focus groups to derive a 40-item model of fatigue and energy. Collaborative engagement with patient research partners supported refinement of questionnaire structure and content further. Pre-testing with ten patients across two interview rounds in stage 3 produced a four-domain, 30-item long-form questionnaire. CONCLUSION: An active collaboration with patients and health-care professionals has supported the co-production of a potential new PROM of axSpA fatigue, underpinned by strong evidence of face and content validity. The WASTEd extends the assessment of fatigue beyond severity, highlighting the importance of symptom frequency, energy and self-management. Future research will involve psychometric evaluation, supporting item reduction, structural refinement and confirmation of PROM validity. Oxford University Press 2022-04-04 /pmc/articles/PMC9021732/ /pubmed/35465627 http://dx.doi.org/10.1093/rap/rkac027 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Pearson, Nathan A
Tutton, Elizabeth
Martindale, Jane
Strickland, George
Thompson, Jean
Packham, Jonathan C
Creamer, Paul
Haywood, Kirstie L
Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
title Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
title_full Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
title_fullStr Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
title_full_unstemmed Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
title_short Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
title_sort development of the warwick axial spondyloarthritis fatigue and energy questionnaire (wasted)—a new patient-reported outcome measure
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021732/
https://www.ncbi.nlm.nih.gov/pubmed/35465627
http://dx.doi.org/10.1093/rap/rkac027
work_keys_str_mv AT pearsonnathana developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure
AT tuttonelizabeth developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure
AT martindalejane developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure
AT stricklandgeorge developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure
AT thompsonjean developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure
AT packhamjonathanc developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure
AT creamerpaul developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure
AT haywoodkirstiel developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure